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Abstract
Background: Malignacies are still a major public concern worldwide and despite the intensive search for new
chemotherapeutic agents, treatment still remains a challenging issue. This work was designed to assess the cytotoxicity of
six selected Cameroonian medicinal plants, including Nauclea pobeguinii and its constituents 3-acetoxy-11-oxo-urs-12-ene
(1), p-coumaric acid (2), citric acid trimethyl ester (3), resveratrol (4), resveratrol β-D-glucopyranoside (5) and strictosamide
(6), against 8 drug-sensitive and multidrug-resistant (MDR) cancer cell lines.
Methods: The resazurin reduction assay was used to evaluate the cytotoxicity of the crude extracts and compounds,
whilst column chromatography was used to isolate the constituents of Nauclea pobeguinii. Structural characterization
of isolated compounds was performed using nuclear magnetic resonance (NMR) spectroscopic data.
Results: Preliminary experiments on leukemia CCRF-CEM cells at 40 μg/mL showed that the leaves and bark extracts
from Tragia benthamii, Canarium schweinfurthii, Myrianthus arboreus, Dischistocalyx grandifolius and Fagara macrophylla
induced more than 50 % growth of this cell line contrary to the leaves and bark extracts of N. pobeguinii. IC50 values
below or around 30 μg/mL were obtained with leaves and bark extracts of N. pobeguinii towards two and five,
respectively, of the 8 tested cancer cell lines. The lowest IC50 value was obtained with the bark extract of N. pobeguinii
against HCT116 (p53−/−) colon cancer cells (8.70 μg/mL). Compounds 4 and 6 displayed selective activity on leukemia and
carcinoma cells, whilst 1–3 were not active. IC50 values below 100 μM were recorded with compound 5 on all 9 tested
cancer cell lines as well as with 4 against 7 out of 8 and 6 against 2 out of 8 cell lines.
Collateral sensitivity was observed in CEM/ADR5000 leukemia cells, MDA-MB-231-BCRP breast adenocarcinoma cells
(0.53-fold), HCT116 (p53+/+) cells, human U87MG.ΔEGFR glioblastome multiforme cells to the methanolic bark extract
of N. pobeguinii, as well as in MDA-MB-231-BCRP cells and HCT116 (p53+/+) cells and U87MG.ΔEGFR cells (0.86-fold) to
compound 5.
Conclusions: The results of this study demonstrate the cytotoxicity of six Cameroonian medicinal plants, Canarium
schweinfurthii, Dischistocalyx grandifolius, Tragia benthamii, Fagara macrophylla, Myrianthus arboreus and Nauclea
pobeguinii. We also demonstrated the antiproliferative potential of Nauclea pobeguinii against drug-resistant cancer
cell lines. Resveratrol and its glucoside are the major cytotoxic constituents in the bark of Nauclea pobeguinii.
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Background
Malignacies are still a major public concern worldwide
and despite the intensive search for new chemothera-
peutic agents, treatment still remains a challenging
issue. The situation is more complicated by the spread
of drug resistance in tumors. Continuous efforts are
necessary to boost drug discovery to treat multidrug
resistant (MDR) cancer cells. Many factors are in-
volved in MDR, including the over-expression of ABC
transporters, particularly breast cancer resistance pro-
tein (BCRP) and P-glycoprotein (P-gp) [1], as well as
the epidermal growth factor receptor (EGFR) [2–4]
and mutations in the p53 tumor suppressor gene [5].
MDR cancer cells are resistant to a variety of chem-
ically unrelated drugs [6–9]. In our previous studies,
we documented the cytotoxicity of several secondary
metabolites from selected Cameroonian plants against
MDR cancer cells [10–15]. In our continous search for
potentially antineoplastic agents from Cameroonian
medicinal plants, the present study was designed at in-
vestigating the cytotoxicity of Canarium schweinfurthii
Engl. (Burseraceae), Dischistocalyx grandifolius C.B.
Clarke (Acanthaceae) and Tragia benthamii Bak. (Eu-
phorbiaceae), Fagara macrophylla Engl. (Rutaceae),
Myrianthus arboreus P. Beauv. (Moraceae) and Nau-
clea pobeguinii (Pobég. ex Pellegr.) Merr. ex E.M.A.
(Rubiaceae). The work was extended to the isolation of
the active constituents of Nauclea pobeguinii. The
above plants are used in Africa to treat many different
ailments (Table 1). However, it has been recommended
that ethnopharmacological usages such as immune and
skin disorders, inflammatory, infectious, parasitic and
viral diseases should be taken into account when
selecting plants used to treat cancer, since these reflect
disease states bearing relevance to cancer or cancer-
like symptoms [16, 17].
Methods
General procedure
Vacuum liquid chromatography (VLC), column chro-
matography (CC) and thin layer chromatography
(TLC) were performed on silica gel 60 (particle size
90 % <45 mm), 200–300 mesh silica gel, and silica gel
GF254 (Merck), respectively. Melting points (m.p.)
were measured by an Electro thermal IA 9000 digital
melting point apparatus (Electro thermal) and are un-
corrected. The NMR data were recorded with a Bruker
DRX-400 MHz (Bruker). LR-EI-MS were recorded with
JEOL mass spectrometer instrument (JEOL). The
purity of the molecules was determined by HPLC
(Shimadzu HPLC system), using a LiChrospher100 RP-
18 (250 × 4 mm, 5 μM) column and MeOH-H2O (6:4
and 8:2)/0.1 TEA as mobile phase with detection at
273 nm.
Chemicals
Doxorubicin 98.0 % from Sigma-Aldrich was provided
by the University Pharmacy of the Johannes Gutenberg
University-Mainz and dissolved in PBS (Invitrogen) at a
concentration of 10 mM. Geneticin >98 % (72.18 mM)
was obtained from Sigma-Aldrich.
Plant material
The plant materials used in this study were the bark of
Canarium schweinfurthii Engl. (Burseraceae), the whole
plant of Dischistocalyx grandifolius C.B.Clarke (Acantha-
ceae) and Tragia benthamii Bak. (Euphorbiaceae), the
bark and leaves of Fagara macrophylla Engl. (Rutaceae),
Myrianthus arboreus P.Beauv. (Moraceae), Nauclea
pobeguinii (Pobég. ex Pellegr.) Merr. ex E.M.A. (Rubia-
ceae). The plant materials were collected in March and
April 2013 in Bangangté and Mbouda (west region of
Cameroon). They were identified at the National Herbar-
ium in Yaoundé, Cameroon and compared with voucher
specimens formerly kept under the registration number
(Table 1).
Extraction
Air-dried plant material (3 kg for the bark of Nauclea
pobeguinii and 1 kg for other samples) was powdered and
extracted with methanol (MeOH; 10 L for the bark of
Nauclea pobeguinii and 3 L for other samples) for two
days. The organic solution was concentrated in vacuo to
yield a paste (crude extract). The yield of each extract was
determined (Table 1) and the samples were kept at 4 °C
until further use.
Isolation of compounds from the bark of nauclea
pobeguinii
The crude extract (80 g) was further poured onto dis-
tilled water and separated with dichloromethane (DCM)
(A), ethyl acetate, EA (B), and n-butanol, n-BuOH (C)
under the non-miscible liquid-liquid process. The con-
centration in vacuo of each organic portion afforded
fractions A (42 g), B (12 g), and C (28 g), respectively. A
column (5 × 60 cm) was used for the purification of frac-
tion A. Silica gel (160 g) column chromatography was
prepared and A was eluted under gradient conditions
with pure (100 %) hexane (hex) and EA affording 75
fractions of 100 mL each. A colorless powder (1, 10 mg)
was obtained from sub-fractions 15–20, while a brown
oil (2, 3.5 mg) was isolated from sub-fractions 25–27. A
colorless sticky gum (3, 11.2 mg) was further obtained
from sub-fractions 50–63. Moreover, fraction B was
loaded onto a silica gel (50 g) column (2 cm × 50 cm)
and the column was eluted with DCM/EA (98:2, v/v) to
give exclusively 2.1 mg of a brownish solid (4). Fraction
C was also loaded onto the same column as A using
150 g of silica gel. The column was eluted with pure
Kuete et al. BMC Complementary and Alternative Medicine  (2015) 15:309 Page 2 of 9
Table 1 Investigated plants, their traditional use, chemical constituents and bioactivities
Species (family); Voucher number*
and place of plant’s collection
Parts used traditionally
(part used in this study
and percentage yield)








coughs, chest pains, pulmonary
affections, stomach complaints,
food poisoning, purgative and
emetic, roundworm infections
and other intestinal parasites,
emollient, stimulant, diuretic,
skin-affections, eczema, leprosy,
ulcers [40]; diabetes mellitus [41];
colic, stomach pains, pains after




From oil: Limonene, phellandrenes [40];
bark: Triterpenes steroids, saponins,
lipids and glycosides [41]; seeds:
schweinfurthinol, p-hydroxybenzaldehyde,
coniferaldehyde, p-hydroxycinnamaldehyde,
ligballinol, amantoflavone [44]; catechol,
dihydroxyphenylacetic acid, tyrosol,
p-hydroxybenzoic acid, dihydroxynezoic
acid, vanilic acid, phloretic acid, pinoresinol,
secoisolariciresinol [45]; tannins,
cardiacglycosides, balsams, phenols
and flavonoids (Uzama et al., 2012),
canarene [46].
Chemoprevention of cancer and other oxidative
damage-induced diseases: fruit mesocarp oil
extract (Atawodi, 2010) and seed kernel oil
extract [47]; Antimycobacterial activities: leaves
[48]; antimicrobial activities of dichloromethane,
ethylacetate and ethanol extracts against











Bark, leaves and seeds
(bark: 8.43 %; leaves:
6.81 %)










tyramine, flavonoid: hesperidin [53–56]
Antiplasmodial :bark [55]; Antifeedant:
xanthoxoline and 1-hydroxy-3-methoxy-
N-methyl-acridone, arborinine,
tembetarine and magnoflorine against
Spodoptera frugiperda, S. littoralis and S.
frugiperda [54]; Low cytotoxicity: seeds
extract towards leukemia CCRF-CEM and
CEM/ADR5000 cells lines and pancreatic
cancer MiaPaCa-2 cell line [52]; Antitumor:












boils, toothache, bronchitis, sore
throat [58]; headaches, swellings
and tumours, diabetes [40];
stomach disorders [59].
Aqueous and methanol extracts: alkaloids,
flavonoid, tannins Cyanogenic glycosides,
Phytic acid, saponin, anthocyanin, glycoside,
carotenoid, oxalate [58, 60].
Antibacterial: against Klebsiella pneumoniae,
Proteus vulgaris, Staphylococcus aureus, E. coli
oxalate [58]; antiplasmodial: against Anopheles
gambiae [61].
Nauclea pobeguinii (Pobég.




(bark: 6.55 %; leaves:
6.31 %)
Abortive, stomach ache, infectious
diseases [62]; jaundice [63]; fever,
diarrhoea, worm, malaria [64].
Nauclefine 1 and 2, strictosamide,
carboxystrictosidine, methylangustoline,
3-O-β-D-fucosyl-quinovic-acid,
3-keto-quinovic-acid [62]; angustoline [65].
Antiplasmodial: extract and
3-O-β-fucosylquinovic







(whole plant: 5.18 %)
Sores, swollen armpit, abortifacient,
child delivery promoter [66].






















DCM/MeOH under gradient condition to afford 90 frac-
tions. Sub-fractions 2–10 afforded 5 mg of compound 4,
while sub-fractions 30–40 pooled together based on
TLC profile gave a colorless solid (5, 5 mg). Similarly, a
yellow solid (6, 20 mg) was obtained after filtration of
sub-fractions 60–75. These sub-fractions were pooled
together based on the TLC profile, after complete evap-
oration, the solid residue was recrystallized with acetone
to give again 6 (15 mg).
Structural characterization of isolated compounds
The structures of compounds (1–6) (Fig. 1) were estab-
lished based on 1D (1H, and 13C) and 2D (HSQC, COSY
and HMBC) NMR spectroscopy as well as mass spec-
trometry. After comparing the obtained data (Additional
file 1: See Supporting information S1) with those reported
in the literature, the compounds were identified as 3-
acetoxy-11-oxo-urs-12-ene (1), p-coumaric acid (2), citric
acid trimethyl ester (3), resveratrol (4), resveratrol β-D-glu-
copyranoside (5) and strictosamide (6).
Cell cultures
The cell lines used in the present work, their origins
and their treatments were previously reported [18, 19].
They include drug-sensitive leukemia CCRF-CEM
cells, its multidrug-resistant subline CEM/ADR5000
cells [3, 20, 21], breast cancer MDA-MB-231-pcDNA3
cells, its resistant subline MDA-MB-231-BCRP clone
23) cells [22], colon HCT116 (p53+/+) cancer cells, its
knockout clones HCT116 (p53−/−), glioblastoma U87MG
cells, its resistant subline U87MG.ΔEGFR cells and nor-
mal AML12 hepatocytes [14, 15, 19, 23]. The CCRF-CEM
and CEM/ADR5000 leukemia cells were maintained in
RPMI 1640 medium (Invitrogen) supplemented with 10 %
fetal calf serum in a humidified 5 % CO2 atm at 37 °C.
Breast cancer cells, transduced with control vector (MDA-
MB-231-pcDNA3) or with cDNA for the breast cancer
resistance protein BCRP (MDA-MB-231-BCRP clone 23),
were maintained under standard conditions as described
above for CCRF-CEM cells. Human wild-type HCT116
(p53+/+) colon cancer cells as well as knockout clones
HCT116 (p53−/−) derived by homologous recombination
were a generous gift from Dr. B. Vogelstein and H.
Hermeking (Howard Hughes Medical Institute, Baltimore,
MD). Human glioblastoma multiforme U87MG cells (non-
transduced) and U87MG cell line transduced with an
expression vector harboring an epidermal growth factor
receptor (EGFR) gene with a genomic deletion of exons 2
through 7 (U87MG.ΔEGFR) were kindly provided by
Dr. W. K. Cavenee (Ludwig Institute for Cancer Research,
San Diego, CA). MDA-MB-231-BCRP, U87MG.ΔEGFR
and HCT116 (p53−/−) were maintained in DMEM
medium containing 10 % FBS (Invitrogen) and 1 % peni-
cillin (100 U/mL)-streptomycin (100 μg/mL) (Invitrogen)
and were continuously treated with 800 ng/mL and
400 μg/mL geneticin, respectively. Normal AML12 hepto-
cytes were obtained from the American Type Culture
Collection (ATCC, USA). The above medium without
geneticin was used to maintain MDA-MB-231, U87MG,
HCT116 (p53+/+) and AML12 cell lines. The cells were
passaged twice weekly. All experiments were performed
with cells in the logarithmic growth phase.
Resazurin reduction assay
The cytotoxicity of the tested samples was performed
by resazurin reduction assay as we previously described
Fig. 1 Chemical structures of the compounds isolated from Nauclea pobeguinii. 1: 3-acetoxy-11-oxo-urs-12-ene; 2: p-coumaric acid; 3: citric acid
trimethyl ester; 4: resveratrol; 5: resveratrol β-D-glucopyranoside; 6: strictosamide
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[14, 15, 18, 19, 24, 25]. Briefly, adherent cells at 1 × 104
cells were allowed to attach overnight and were then
treated with different concentrations of the studied
samples. For suspension cells, aliquots of 2 × 104 cells
per well were seeded in 96-well-plates in a final volume
of 200 μL. Extracts and compounds were prior diluted
in DMSO and tested in a final concentration below
0.1 % (A final concentration of 0.1 % DMSO was used
as negative control and did not show any effect on cell
growth). After 72 h incubation and resazurin (Sigma-
Aldrich, Schnelldorf, Germany) staining, fluorescence
was measured on an Infinite M2000 Pro™ plate reader
(Tecan, Crailsheim, Germany) using an excitation
wavelength of 544 nm and an emission wavelength of
590 nm. Each assay was done at least two times, with
six replicates each. IC50 values represent the sample
concentration required to inhibit 50 % of cell prolifera-
tion and were calculated from a calibration curve by
linear regression using Microsoft Excel.
Results and discussion
Compounds were identified as 3-acetoxy-11-oxo-urs-12-
ene C32H50O3 (1; m.p. 282.1-283.4 °C; m/z: 482.4; purity:
90 %)[26], p-coumaric acid C9H8O3 (2; m/z: 164.0; purity:
97 %)[27], citric acid trimethyl ester C9H14O7 (3; m/z:
234.0; purity: 97 %)[28], resveratrol C14H12O3 (4; m/z:
228.1; purity: 98 %)[29], resveratrol β-D-glucopyranoside
C20H22O8 (5; m/z: 390.1; purity: 95 %)[30], and strictosa-
mide C26H30N2O8 (6; m/z: 498.2; purity: 96 %) [31]. The
irido-indole alkaloid strictosamide (6, 35 mg) was the
major constituent of the bark extract. This is in accord-
ance with previous studies reporting 6 as the main
compound isolated from the bark methanolic extract of
Nauclea pobeguinii harvested in Democratic Republic of
Congo [32]. However, Xu et al. [32] also identified several
other alkaloids as minor constituents of the bark extract,
such as naucleidinic acid and 19-O-methyl-3,14-dihy-
droangustoline, naucleidinal, magniflorine, naucleofficine
D, 3,14-dihydroangustoline, strictosidine, desoxycordifo-
line, 3a,5a-tetrahydrodeoxycordifoline lactam, and a phe-
nol kelampayoside A. These compounds were not isolated
in our sample from Cameroon. In addition, compounds
1–5 reported in this study were also not found in the plant
harvested in Congo. This could either be due to the isola-
tion techniques used or to the environmental variation
that influences the concentration of the minor constitu-
ents synthesized by the Nauclea pobeguinii. strictosamide
(6) was obtained as the major constituent isolated from
the methanolic extract in both cases.
A preliminary cytotoxicity study was first carried out
on leukemia CCRF-CEM cells with crude extracts at a
single concentration of 40 μg/mL for crude extracts.
Doxorubicin (10 μM) served as positive control. Accord-
ing to the National Cancer Institute (USA), 30 μg/mL is
the upper IC50 limit considered promising for purifica-
tion of a crude extract [33]. We tested a slightly higher
concentration (of 40 μg/mL) in our preliminary assay.
The results depicted in Fig. 2 show that more than 50 %
growth was obtained if CCRF-CEM cells were treated
with the methanol extracts from Tragia benthamii
(63.7 %), Canarium schweinfurthii (59.96 %), Myrianthus
arboreus (57.8 %), Dischistocalyx grandifolius (56.8 %)
and Fagara macrophylla leaves (52.0 %). Only the crude
extracts from the leaves (36.6 %) and bark (33.0 %) of
Fig. 2 Growth percentage (%) of CCRF-CEM leukemia cells treated with plant extracts and doxorubicin. Samples were tested at a single concentration
of 40 mg/mL for crude extracts and of 10 μM for doxorubicin
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Nauclea pobeguinii as well as doxorubicin (13.6 %) were
able to induce more than 50 % inhibition of CCRF-CEM
leukemia cell growth (Fig. 2). The IC50 values of extracts
(bark and leaves) from Nauclea pobeguinii were further
determined on eight cancer cell lines and values below
30 μg/mL were obtained both extracts towards two out
of eight and five out of eight cell lines, respectively
(Table 2). The lowest IC50 value of 8.70 μg/mL was
obtained with the bark extract against HCT116 (p53−/−)
cells. Consequently, this extract was subjected to purifi-
cation from which six compounds (1–6) were obtained.
Compounds 4 and 6 displayed selective activities on the
studied cancer cell lines. IC50 values below 100 μM were
recorded with compound 5 on all eight tested cancer cell
lines. IC50 values below 175.36 μM and 80.29 μM (for 4
and 6 respectively) were also obtained against seven out
of eight cell lines for 4 and two out of eight cell lines for
6. The IC50 values ranged from 25.08 μM (towards
CCRF-CEM cells) to 97.64 (towards MDA-MB231 cells)
for compound 5 and from 0.20 μM (against CCRF-CEM
cells) and 195.12 μM (against CEM/ADR5000 cells) for
doxorubicin. No IC50 values were obtainable, if com-
pound 1 was tested at up to 82.92 μM. The same is true
for compounds 2 (>243.90 μM) and 3 (>170.94 μM).
The best compounds (4 and 5) were less toxic towards
AML12 normal hepatocytes than against cancer cells.
The IC50 threshold values of 20 μg/mL for crude ex-
tracts as well as 4 μg/mL or 10 μM for compounds [34,
35] after 48 and 72 h incubation have been set by the
United States National Cancer Institute (USNCI) to
identify good cytotoxic phytochemicals. None of the
tested compounds displayed IC50 values below 10 μM.
However, the bark extract of Nauclea pobeguinii (IC50
value below 20 μg/mL on four out of eight tested cancer
cell lines) could be considered as a promising candidate
to fight cancers. The best isolated compounds (4–6)
displayed rather moderate activities, suggesting possible
synergistic effects of constituents in the crude extract.
The development of MDR in cancer cells either
through ABC transporters [36], the epidermal growth
factor receptor (EGFR) [2–4], or the tumor suppressor
p53 gene [5] represents a major hurdle in chemotherapy.
The discovery of new compounds with activity against
MDR is hence very important in the ongoing fight
against malignancies. In the present study, we used cell
lines possessing all these resistance mechanisms to in-
vestigate multi-factorial drug resistance. The degrees
of resistance were determined as the ratio of IC50 value
of the resistant cell line to that of the corresponding
parental sensitive counterpart (Table 2). Compared to
their corresponding sensitive cell lines, collateral sensi-
tivity in resistant cells (hypersensitivity) was observed
in P-glycoprotein-overexpressing CEM/ADR5000 cells
(degree of resistance 0.80-fold), BCRP-overexpressing
MDA-MB-231-BCRP cells (0.53-fold), p53 HCT116
(p53−/−) knockout cells (<0.54-fold) and epidermal
growth factor receptor-overexpressing U87MG.ΔEGFR
cells (0.47-fold) to the bark extract of N. pobeguinii. Col-
lateral sensitivity was also found in HCT116 (p53−/−) cells
(0.74-fold) and U87MG.ΔEGFR cells (0.86-fold) to com-
pound 5.
The obtained data indicates that the stilbene resvera-
trol glucoside 5 and its aglycon 4 displayed slightly dif-
ferent degrees of activity on the cancer cell lines studied.
This shows that glucosylation may positively (especially
in leukemia cells) influence the cytotoxic activity. In fact,
resveratrol glucoside 5 was more active than its aglcon 4
on the two tested leukemia cells. However, in carcinoma
cell lines, the cytotoxicity of compounds 4 and 5 varied
from one cell lines to other, none of two being more
active than other one in all the solid cancer cell lines
tested. To the best of our knowledge, this phytochemical
and cytotoxicity study of the crude bark and leaf extracts
as well as compounds 1–3 and 5 of Nauclea pobeguinii
towards multifactorial drug resistant cancer lines is
being reported here for the first time. Though strictosa-
mide (6) is known to be the main constituent [32] of this
plant, the present study suprisingly showed that it was
not the most cytotoxic component of the extracts
against the studied cancer cell lines. The best activities
were reported with stilbenes namely resveratrol (4) and
it glycoside resveratrol β-D-glucopyranoside (5). Com-
pound 4 is a well known cytotoxic agent [37–39]. It is
reported to suppress the proliferation of SKBR-3 breast
cancer cells by inhibiting fatty acid synthase signaling
pathway [38]. Compound 4 also alleviates the PI3K/Akt/
mTOR signaling in breast cancer SKBR-3cells by down-
regulation of Akt phosphorylation and up-regulation of
PTEN expression [38]. Besides, compound 4 reportedly
reverses MDR of the MCF-7/DOX breast cancer cells
[39]. In the present study, compound 4 was most effect-
ive (IC50 < 23 μM) against MDA-MB231 breast adeno-
carcinoma cells and their drug-resistant, MDA-MB231/
BCRP. These data are in accordance with previous
reports and consolidates the potential cytotoxicity of 4
against breast cancer cells.
Conclusion
In conclusion, we demonstrate the cytotoxic potential of
six Cameroonian medicinal plants, Canarium schwein-
furthii, Dischistocalyx grandifolius, Tragia benthamii,
Fagara macrophylla, Myrianthus arboreus and Nauclea
pobeguinii. We also demonstrated the cytotoxic potential
of leaves and bark of Nauclea pobeguinii against sensi-
tive and MDR cancer cell lines. We further identified
resveratrol and its β-glucoside as major cytotoxic con-
stituents of the bark of Nauclea pobeguinii. The bark
and leaves extracts of Nauclea pobeguinii are potential
Kuete et al. BMC Complementary and Alternative Medicine  (2015) 15:309 Page 6 of 9
Table 2 Cytotoxicity of extracts and compounds from Nauclea pobeguinii towards sensitive and drug-resistant cancer cell lines and normal cells as determined by the resazurin
assay
Cell lines Tested samples, IC50 values and degrees of resistance (in bracket)
Crude extracts and IC50 values (μg/mL) IC50 values of compounds (μM) IC50 values of
doxorubicin (μM)NPB NPL 1 2 3 4 5 6
CCRF-CEM 14.62 ± 1.23 25.84 ± 2.16 >82.92 >243.90 >170.94 28.15 ± 1.32 25.08 ± 2.48 77.10 ± 5.87 0.20 ± 0.06
CEM/ADR5000 11.56 ± 0.85 (0.80) 25.55 ± 1.63 (0.99) >82.92 (n.a) >243.90 (n.a) >170.94 (n.a) 57.43 ± 3.67 (2.04) 39.87 ± 2.91 (1.59) >80.29 (>1.04) 195.12 ± 14.30 (975.60)
MDA-MB231 37.00 ± 2.91 64.75 ± 5.08 >82.92 >243.90 >170.94 19.90 ± 1.45 97.64 ± 7.60 >80.29 1.10 ± 0.28
MDA-MB231/BCRP 19.79 ± 2.13 (0.53) 59.55 ± 4.21 (0.92) >82.92 (n.a) >243.90 (n.a) >170.94 (n.a) 22.93 ± 1.64 (1.15) 95.59 ± 8.17 (0.98) 78.26 ± 6.22 (<0.97) 7.83 ± 0.47 (7.12)
HCT116 (p53+/+) 16.19 ± 1.16 32.78 ± 2.67 >82.92 >243.90 >170.94 73.65 ± 5.67 63.77 ± 4.61 >80.29 1.41 ± 0.29
HCT116 (p53−/−) 8.70 ± 0.68 (0.54) 19.39 ± 1.34 (0.59) >82.92 (n.a) >243.90 (n.a) >170.94 (n.a) >175.36 (>2.38) 47.03 ± 4.94 (0.74) >80.29 (n.a) 4.06 ± 0.07 (2.88)
U87MG 69.44 ± 4.34 >40 >82.92 >243.90 >170.94 76.59 ± 4.92 55.64 ± 3.73 >80.29 1.06 ± 0.15
U87MG.ΔEGFR 32.78 ± 2.79 (0.47) 63.90 ± 4.77 (>1.60) >82.92 (n.a) >243.90 (n.a) >170.94 (n.a) 28.45 ± 2.06 (0.37) 47.59 ± 3.29 (0.86) >80.29 (n.a) 6.11 ± 0.57(5.76)
AML12 >40 >40 >82.92 >243.90 >170.94 >175.36 >102.56 >80.29 >73.59
(*): The degree of resistance was determined as the ratio of IC50 value in the resistant divided by the IC50 in the sensitive cell line; NPB: extract from the bark of Nauclea pobeguinii; NPL: extract from the leaves of
Nauclea pobeguinii; Compounds isolated from NPB [1: 3-acetoxy-11-oxo-urs-12-ene; 2: p-coumaric acid; 3: citric acid trimethyl ester; 4: resveratrol; 5: resveratrol β-D-glucopyranoside; 6: strictosamide]; n.a.: not


















cytotoxic botanicals that deserves more investigations to
develop novel cytotoxic phytomedicines against drug-
resistant cancers.
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